Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05733286 · ClinicalTrials.gov registry record · Phase 2
REPOSE Study: Reducing Delirium by Enhancing Postoperative Sleep With Suvorexant
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 142
- Enrollment target
NCT05733286 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 142 participants.
The verdict
NCT05733286, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 142 participants
- Enrollment target
Study Summary
This research study will evaluate the effectiveness of postoperative administration of a drug called suvorexant, to improve postoperative sleep and decrease the severity of delirium (serious confusion) in adults 65 years and older undergoing non-cardiac surgery.
Interventions
- DRUG Placebo
- DRUG Suvorexant 20 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2023-06-28 |
| Est. Completion | 2025-07-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05733286
The ClinicalTrials.gov registry entry for NCT05733286 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05733286 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05733286 about?
NCT05733286 is a clinical study titled "REPOSE Study: Reducing Delirium by Enhancing Postoperative Sleep With Suvorexant". This research study will evaluate the effectiveness of postoperative administration of a drug called suvorexant, to improve postoperative sleep and decrease the severity of delirium (serious confusion) in adults 65 years and older undergoing non-cardiac surgery.
What is the current status of trial NCT05733286?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 142 participants. The study started on 2023-06-28. Estimated completion is 2025-07-07.
What interventions are being tested in trial NCT05733286?
The interventions under investigation include: Placebo (DRUG), Suvorexant 20 mg (DRUG).
Who is sponsoring clinical trial NCT05733286?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.